We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information and guidance related to the Sciencewise programme.
This paper sets out principles for when the CMA will use field and online experiments and describes best practice for conducting them.
How to use an interrupted time series to evaluate your digital health product.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
Dstl's simulation capability, the Virtual Proving Ground, enabled users to test emerging technologies during a recent Army Warfighting Experiment.
How to begin with evaluating a digital health product, including when to evaluate, budgeting and getting support.
How to use chatbots and webchat tools to improve your users’ experience of your service.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Services that the team provide to academics and officials
Climate change is happening and is due to human activities; along with warming, many other changes are occurring such as melting polar ice, rising sea levels and more frequent floods, droughts and heatwaves.
This document contains the following information: Investigation into the Home Office's regulation of animal experimentation: 1st report, session 2006-07
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
List of manufacturers and their medical devices granted an exemption by MHRA. The list also includes manufacturers whose exemption expired or was cancelled.
This amended guidance was issued under s 182 of the Licensing Act 2003.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.